Repository logo
 
Publication

Acyloxymethyl as a drug protecting group. Part 6

dc.contributor.authorLopes, F
dc.contributor.authorMoreira, R
dc.contributor.authorIley, J
dc.date.accessioned2015-12-30T10:17:40Z
dc.date.available2015-12-30T10:17:40Z
dc.date.issued2000
dc.description.abstractTertiary N-acyloxymethyl- and N-[(aminocarbonyloxy)methyl]sulfonamides were synthesised and evaluated as novel classes of potential prodrugs of agents containing a secondary sulfonamide group. The chemical and plasma hydrolyses of the title compounds were studied by HPLC, Tertiary N-acyloxymethylsulfonamides are slowly and quantitatively hydrolysed to the parent sulfonamide ill pH 7.4 phosphate buffer, with half-lives ranging from 20 h, for 7d, to 30 days, for 7g. Quantitative formation of the parent sulfonamide also occurs in human plasma, the half-lives being within 0.2-2.0 min for some substrates. The rapid rate of hydrolysis can be ascribed to plasma cholinesterase, as indicated by the complete inhibition observed at. [eserine] = 0.10 mM. These results suggest that tertiary N-acyloxymethylsulfonamides are potentially useful prodrugs for agents containing a secondary sulfonamide group, especially with pK(a) 8, combining a high stability in aqueous media with a high rate of plasma activation. In contrast, N-[(aminocarbonyloxy)methyl]sulfonamides 7h-j do not liberate the parent sulfonamide either in aqueous buffers or in human plasma and thus appear to be unsuitable for development as sulfonamide prodrugs. (C) 2000 Elsevier Science Ltd. All rights reserved.
dc.formatapplication/pdf
dc.identifier.citationBIOORGANIC & MEDICINAL CHEMISTRY. - Vol. 8, n. 4 (APR 2000), p. 707-716
dc.identifier.issn0968-0896
dc.identifier.urihttp://hdl.handle.net/10451/21191
dc.language.isoeng
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD
dc.subjectBiochemistry & Molecular Biology
dc.subjectChemistry, Medicinal
dc.subjectChemistry, Organic
dc.titleAcyloxymethyl as a drug protecting group. Part 6
dc.titleN-acyloxymethyl- and N-[(aminocarbonyloxy)methyl]sulfonamides as prodrugs of agents containing a secondary sulfonamide group
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage716por
oaire.citation.startPage707por
oaire.citation.titleBIOORGANIC & MEDICINAL CHEMISTRYpor
oaire.citation.volumeVol. 8por
rcaap.rightsrestrictedAccess
rcaap.typearticle

Files